Drug Approval | April 14, 2026
CDSCO reforms cut trial approval timelines by over 50%: DCGI Dr Rajeev Raghuvanshi
Outlines 1,500-member internal cadre, digital regulatory system, and faster SEC-led reviews
Outlines 1,500-member internal cadre, digital regulatory system, and faster SEC-led reviews
Former Global Head of IT & Digital Transformation at Biocon Biologics steps into enterprise-wide technology leadership role
Surgeon Yuvaraja operates on a 55-year-old patient at Medical City Hospital Muscat
Veteran HR leader comes with over two decades of experience to spearhead talent strategy, leadership development, and culture transformation
With more than two decades of experience, he brings deep expertise in sales, marketing, business transformation, and strategic leadership
In his new role, Saran will spearhead the end-to-end launch framework for innovation-led portfolio
Company leadership is framing the move as transformational.
Industry, policymakers focus on AI-led regulatory harmonisation, FTAs, MSME support and market expansion as exports touch $28.29 billion till February FY26
18-year veteran Saharsh will position the CDMO as a premier global API process development and commercial manufacturing specialist
The acquisition brings two commercialized, differentiated medicines—EMPAVELI and SYFOVRE —to Biogen’s growth portfolio
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
